Get the Stockscreener App
24.50
0.33%
-0.08
After Hours:
24.50
Kestra Medical Technologies Ltd stock is traded at $24.50, with a volume of 135.35K.
It is down -0.33% in the last 24 hours and down -1.13% over the past month.
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
See More
Previous Close:
$24.58
Open:
$24.32
24h Volume:
135.35K
Relative Volume:
1.20
Market Cap:
$1.22B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.24%
1M Performance:
-1.13%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$24.21
$25.34
1-Week Range:
$22.00
$26.15
52-Week Range:
$20.00
$26.15
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
Name
Kestra Medical Technologies Ltd
Sector
Industry
Phone
(425) 279-8002
Address
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Compare KMTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
24.50 | 1.22B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
482.74 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
198.71 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.54 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
212.91 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.51 | 15.75B | 3.90B | 392.30M | 288.10M | 1.95 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Initiated | BofA Securities | Buy |
| Mar-31-25 | Initiated | Goldman | Neutral |
| Mar-31-25 | Initiated | Piper Sandler | Overweight |
| Mar-31-25 | Initiated | Stifel | Buy |
| Mar-31-25 | Initiated | Wells Fargo | Overweight |
| Mar-31-25 | Initiated | Wolfe Research | Outperform |
View All
Kestra Medical Technologies Ltd Stock (KMTS) Latest News
Kestra Medical Technologies (NASDAQ:KMTS) Hits New 52-Week HighTime to Buy? - MarketBeat
The Goldman Sachs Group Lowers Kestra Medical Technologies (NASDAQ:KMTS) Price Target to $23.00 - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Down After Earnings Miss - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Releases Earnings Results - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 4.3% Following Weak Earnings - MarketBeat
Kestra Medical price target lowered to $23 from $24 at Goldman Sachs - TipRanks
Piper Sandler maintains $27 target on Kestra Medical stock By Investing.com - Investing.com South Africa
Piper Sandler maintains $27 target on Kestra Medical stock - Investing.com Australia
Kestra Medical Technologies revenue jumps 82% to USD 15.1M in Q3 FY25 - Medical Buyer
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 4.3% Following Weak Earnings - Defense World
Kestra Medical Technologies Reports Strong Q3 Growth - TipRanks
Truist Financial Q3 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Kestra Medical Q3 FY2025 sees revenue surge By Investing.com - Investing.com India
Earnings call transcript: Kestra Medical Q3 FY2025 sees revenue surge - Investing.com Australia
Kestra Medical Tech Reports Third Quarter Fiscal 2025 Financial Results - marketscreener.com
Kestra Medical reports Q3 EPS ($1.25) vs. ($1.18) last year - TipRanks
Kestra Medical Technologies Reports Third Quarter Fiscal 2025 Financial Results - GlobeNewswire
Kestra Medical Technologies Ltd.: Positioned for Growth with Strong Financials and Innovative Market Strategy - TipRanks
Kestra Medical Technologies, Ltd.'s Quiet Period To End on April 15th (NASDAQ:KMTS) - MarketBeat
Kestra Medical Technologies, Ltd.’s Quiet Period To Expire on April 15th (NASDAQ:KMTS) - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Reaches New 1-Year HighShould You Buy? - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives $27.67 Average Price Target from Brokerages - The AM Reporter
Kestra Medical Technologies (NASDAQ:KMTS) Earns Overweight Rating from Analysts at Piper Sandler - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by The Goldman Sachs Group - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives $27.67 Average Target Price from Analysts - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated at Stifel Nicolaus - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Trading 2.5% HigherTime to Buy? - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Earns Overweight Rating from Analysts at Wells Fargo & Company - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by Wolfe Research - MarketBeat
Nalu Medical Appoints Veteran Medtech Executive Raymond W. Cohen Chairman of its Board of Directors - Yahoo Finance
Analysts Set Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) PT at $27.67 - Defense World
Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14 - The Manila Times
Kestra Medical Technologies (NASDAQ:KMTS) Earns Buy Rating from Analysts at Bank of America - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by Analysts at The Goldman Sachs Group - Defense World
Wells Fargo & Company Begins Coverage on Kestra Medical Technologies (NASDAQ:KMTS) - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by Piper Sandler - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated by Analysts at Stifel Nicolaus - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated by Analysts at Piper Sandler - The AM Reporter
Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated by Analysts at Wells Fargo & Company - Defense World
Kestra Medical Technologies: Strong Growth Potential Balanced by Current Valuation in MedTech Sector - TipRanks
Goldman Sachs Initiates Kestra Medical Technologies at Neutral With $24 Price Target - MarketScreener
This Norwegian Cruise Line Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Stifel Initiates Kestra Medical Technologies at Buy With $28 Price Target - MarketScreener
Kestra Medical Technologies: Positioned for Growth in the Wearable Cardioverter Defibrillator Market - TipRanks
Wolfe Initiates Kestra Medical Technologies at Outperform With $29 Price Target - MarketScreener
Wells Fargo Initiates Kestra Medical Technologies at Overweight With $28 Price Target - Marketscreener.com
Kestra Medical initiated with an Outperform at Wolfe Research - TipRanks
Kestra Medical initiated with a Buy at Stifel - TipRanks
Kestra Medical Technologies: Positioned for Growth with Next-Gen Wearable Cardioverter Defibrillator - TipRanks
Buy Rating for Kestra Medical Technologies Ltd. Driven by Strong Growth Prospects and Strategic Market Positioning - TipRanks
Kestra Medical initiated with an Overweight at Piper Sandler - TipRanks
Kestra Medical Technologies Ltd Stock (KMTS) Financials Data
There is no financial data for Kestra Medical Technologies Ltd (KMTS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.90%
3.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):